Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Califf Tapped To Head FDA

Grants & Funding: Computational chemist to lead agency division

by Britt E. Erickson
September 21, 2015 | A version of this story appeared in Volume 93, Issue 37

President Barack Obama has nominated Robert Califf, a researcher and cardiologist, to serve as commissioner of the Food & Drug Administration. Califf, 63, joined FDA earlier this year as deputy commissioner for medical products and tobacco. In that role he managed the agency’s clinical, scientific, and regulatory initiatives in areas including personalized medicine, orphan drugs, and pediatric science. He also worked to streamline the clinical trials process to get drugs to the market faster. Califf is a leader in the growing field of translational research—work that is essential for transforming scientific advances into medical products such as drugs. He has held several positions at Duke University, including vice chancellor of clinical and translational research, director of the university’s Translational Medicine Institute, founding director of its Clinical Research Institute, and professor of medicine in the division of cardiology at the Duke University Medical Center. Califf is not expected to face significant opposition in the Senate, which must confirm him before he takes the helm of FDA.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.